Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
- 31 October 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 9 (10), 937-945
- https://doi.org/10.1016/s1470-2045(08)70208-0
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening TestJNCI Journal of the National Cancer Institute, 2008
- The Risk of False-Positive Histology According to the Reason for Colposcopy Referral in Cervical Cancer ScreeningAmerican Journal of Clinical Pathology, 2008
- Evaluation of a new p16INK4A ELISA test and a high-risk HPV DNA test for cervical cancer screening: Results from proof-of-concept studyInternational Journal of Cancer, 2007
- Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assayCancer, 2007
- A comparison of the clinical utility of p16INK4a immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasiaCancer, 2006
- Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled TrialJNCI Journal of the National Cancer Institute, 2006
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006
- Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytologyCancer, 2006
- Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening SettingAmerican Journal of Clinical Pathology, 2005
- Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worseAmerican Journal of Obstetrics and Gynecology, 2004